Obeticholic Acid, FXR Agonists, Liver Disease and Plasma Biomarkers (original) (raw)
Efficacy of Obeticholic Acid in Patients with Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Cathi Sciacca, Luciano Adorini
Gastroenterology, 2014
View PDFchevron_right
The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
Laurence Blendis
Hepatology, 1994
View PDFchevron_right
Use of ursodeoxycholic acid in liver diseases
Dinesh Kumar
Journal of Gastroenterology and Hepatology, 2001
View PDFchevron_right
BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID AND LONG-TERM PROGNOSIS IN PRIMARY BILIARY CIRRHOSIS
Ludovico Abenavoli
Digestive and Liver Disease, 2009
View PDFchevron_right
Effect of different doses of ursodeoxycholic acid in chronic liver disease
Andrea Crosignani
Digestive Diseases and Sciences, 1989
View PDFchevron_right
Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid
Andrea Crosignani, Kenneth Setchell
Clinica Chimica Acta, 1996
View PDFchevron_right
Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
Tilman Sauerbruch
Frontiers in Physiology, 2021
View PDFchevron_right
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
J.G.S. Breed
Alimentary Pharmacology and Therapeutics, 1998
View PDFchevron_right
Ursodeoxycholic acid in chronic liver disease
Maria Petroni
Gut, 1991
View PDFchevron_right
Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis
G. Mazzella
2002
View PDFchevron_right
Altered bile acid metabolism in primary biliary cirrhosis
Bernhard Lauterburg
Digestive Diseases and Sciences, 1981
View PDFchevron_right
Diagnostic Effectiveness of Serum Bile Acids in Liver Diseases as Evaluated by Multivariate Statistical Methods
Francesco Rucci
Hepatology, 2007
View PDFchevron_right
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease
José Presa
United European Gastroenterology Journal, 2021
View PDFchevron_right
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial
Miquel Bruguera
Journal of Hepatology, 2000
View PDFchevron_right
Serum bile acid analysis
Kenneth Setchell
Clinica Chimica Acta, 1983
View PDFchevron_right
Treatment of Chronic Liver Disease with Ursodeoxycholic Acid
M. Guslandi
Journal of International Medical Research, 1990
View PDFchevron_right
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
Martin Houben
Gastroenterology, 2009
View PDFchevron_right
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid
Vanessa Ch
Hepatology, 2007
View PDFchevron_right
Moexipril for Treatment of Primary Biliary Cirrhosis in Patients with an Incomplete Response to Ursodeoxycholic Acid
Keith Lindor
Digestive Diseases and Sciences, 2010
View PDFchevron_right
Serum bile acid: an alternative liver function marker in the obstructive jaundice patient
Marzuki Suryaatmadja
Acta medica Indonesiana, 2012
View PDFchevron_right
Ursodeoxycholic acid for primary biliary cirrhosis
Christian Gluud
Reviews, 1996
View PDFchevron_right
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study
evangelos thalassinos
Alimentary Pharmacology & Therapeutics, 2013
View PDFchevron_right
Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial
Melanie Deutsch
The American Journal of Gastroenterology, 2002
View PDFchevron_right
The Resurgence of Serum Alkaline Phosphatase as a Surrogate Biomarker for Prognosis in Primary Sclerosing Cholangitis
Roger Chapman
Clinical Gastroenterology and Hepatology, 2013
View PDFchevron_right
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: First controlled data
Monte Anderson
Hepatology, 1990
View PDFchevron_right
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome
Keith Lindor
The American journal of gastroenterology, 2018
View PDFchevron_right
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease
Professor Samy Azer
Journal of Gastroenterology and Hepatology, 1996
View PDFchevron_right
Fenofibrate in Primary Biliary Cirrhosis: A Pilot Study~!2010-03-16~!2010-04-02~!2010-04-28~!
Matilda Florentin
The Open Cardiovascular Medicine Journal, 2010
View PDFchevron_right
Ursodeoxycholic Acid Improves Liver Tests in Chronic Hepatitis
Marco BERTOLOTTI
Clinical Drug Investigation, 1999
View PDFchevron_right